325 related articles for article (PubMed ID: 20376066)
1. Evidence for altered Wnt signaling in psoriatic skin.
Gudjonsson JE; Johnston A; Stoll SW; Riblett MB; Xing X; Kochkodan JJ; Ding J; Nair RP; Aphale A; Voorhees JJ; Elder JT
J Invest Dermatol; 2010 Jul; 130(7):1849-59. PubMed ID: 20376066
[TBL] [Abstract][Full Text] [Related]
2. Wnt/β-Catenin and Wnt5a/Ca Pathways Regulate Proliferation and Apoptosis of Keratinocytes in Psoriasis Lesions.
Zhang Y; Tu C; Zhang D; Zheng Y; Peng Z; Feng Y; Xiao S; Li Z
Cell Physiol Biochem; 2015; 36(5):1890-902. PubMed ID: 26202350
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional profiling shows altered expression of wnt pathway- and lipid metabolism-related genes as well as melanogenesis-related genes in melasma.
Kang HY; Suzuki I; Lee DJ; Ha J; Reiniche P; Aubert J; Deret S; Zugaj D; Voegel JJ; Ortonne JP
J Invest Dermatol; 2011 Aug; 131(8):1692-700. PubMed ID: 21562572
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of Wnt5a in psoriatic plaques.
Reischl J; Schwenke S; Beekman JM; Mrowietz U; Stürzebecher S; Heubach JF
J Invest Dermatol; 2007 Jan; 127(1):163-9. PubMed ID: 16858420
[TBL] [Abstract][Full Text] [Related]
5. Wnt5a exhibits layer-specific expression in adult skin, is upregulated in psoriasis, and synergizes with type 1 interferon.
Romanowska M; Evans A; Kellock D; Bray SE; McLean K; Donandt S; Foerster J
PLoS One; 2009; 4(4):e5354. PubMed ID: 19399181
[TBL] [Abstract][Full Text] [Related]
6. Loss of WIF-1 and Wnt5a expression is related to aggressiveness of sporadic breast cancer in Tunisian patients.
Trifa F; Karray-Chouayekh S; Jmal E; Jmaa ZB; Khabir A; Sellami-Boudawara T; Frikha M; Daoud J; Mokdad-Gargouri R
Tumour Biol; 2013 Jun; 34(3):1625-33. PubMed ID: 23417837
[TBL] [Abstract][Full Text] [Related]
7. Wnt5a is strongly expressed at the leading edge in non-melanoma skin cancer, forming active gradients, while canonical Wnt signalling is repressed.
Pourreyron C; Reilly L; Proby C; Panteleyev A; Fleming C; McLean K; South AP; Foerster J
PLoS One; 2012; 7(2):e31827. PubMed ID: 22384081
[TBL] [Abstract][Full Text] [Related]
8. WIF1 re-expression in glioblastoma inhibits migration through attenuation of non-canonical WNT signaling by downregulating the lncRNA MALAT1.
Vassallo I; Zinn P; Lai M; Rajakannu P; Hamou MF; Hegi ME
Oncogene; 2016 Jan; 35(1):12-21. PubMed ID: 25772239
[TBL] [Abstract][Full Text] [Related]
9. Wnt/β-catenin signaling is hyperactivated in systemic sclerosis and induces Smad-dependent fibrotic responses in mesenchymal cells.
Wei J; Fang F; Lam AP; Sargent JL; Hamburg E; Hinchcliff ME; Gottardi CJ; Atit R; Whitfield ML; Varga J
Arthritis Rheum; 2012 Aug; 64(8):2734-45. PubMed ID: 22328118
[TBL] [Abstract][Full Text] [Related]
10. Wnt5a signaling induces proliferation and survival of endothelial cells in vitro and expression of MMP-1 and Tie-2.
Masckauchán TN; Agalliu D; Vorontchikhina M; Ahn A; Parmalee NL; Li CM; Khoo A; Tycko B; Brown AM; Kitajewski J
Mol Biol Cell; 2006 Dec; 17(12):5163-72. PubMed ID: 17035633
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.
Urakami S; Shiina H; Enokida H; Kawakami T; Tokizane T; Ogishima T; Tanaka Y; Li LC; Ribeiro-Filho LA; Terashima M; Kikuno N; Adachi H; Yoneda T; Kishi H; Shigeno K; Konety BR; Igawa M; Dahiya R
Clin Cancer Res; 2006 Jan; 12(2):383-91. PubMed ID: 16428476
[TBL] [Abstract][Full Text] [Related]
12. The Wnt5a/Ror2 noncanonical signaling pathway inhibits canonical Wnt signaling in K562 cells.
Yuan Y; Niu CC; Deng G; Li ZQ; Pan J; Zhao C; Yang ZL; Si WK
Int J Mol Med; 2011 Jan; 27(1):63-9. PubMed ID: 21069266
[TBL] [Abstract][Full Text] [Related]
13. Caspase-5 expression is upregulated in lesional psoriatic skin.
Salskov-Iversen ML; Johansen C; Kragballe K; Iversen L
J Invest Dermatol; 2011 Mar; 131(3):670-6. PubMed ID: 21191419
[TBL] [Abstract][Full Text] [Related]
14. Frizzled gene expression and negative regulation of canonical WNT-β-catenin signaling in mouse F9 teratocarcinoma cells.
Golenia G; Gatie MI; Kelly GM
Biochem Cell Biol; 2017 Apr; 95(2):251-262. PubMed ID: 28177772
[TBL] [Abstract][Full Text] [Related]
15. WNT pathway in oral cancer: epigenetic inactivation of WNT-inhibitors.
Pannone G; Bufo P; Santoro A; Franco R; Aquino G; Longo F; Botti G; Serpico R; Cafarelli B; Abbruzzese A; Caraglia M; Papagerakis S; Lo Muzio L
Oncol Rep; 2010 Oct; 24(4):1035-41. PubMed ID: 20811686
[TBL] [Abstract][Full Text] [Related]
16. Upregulated miR-374a-5p drives psoriasis pathogenesis through WIF1 downregulation and Wnt5a/NF-κB activation.
Ma J; Gan L; Chen H; Chen L; Hu Y; Luan C; Chen K; Zhang J
Cell Signal; 2024 Jul; 119():111171. PubMed ID: 38604345
[TBL] [Abstract][Full Text] [Related]
17. Quantitative and kinetic profile of Wnt/β-catenin signaling components during human neural progenitor cell differentiation.
Mazemondet O; Hubner R; Frahm J; Koczan D; Bader BM; Weiss DG; Uhrmacher AM; Frech MJ; Rolfs A; Luo J
Cell Mol Biol Lett; 2011 Dec; 16(4):515-38. PubMed ID: 21805133
[TBL] [Abstract][Full Text] [Related]
18. MSX1 induces the Wnt pathway antagonist genes DKK1, DKK2, DKK3, and SFRP1 in neuroblastoma cells, but does not block Wnt3 and Wnt5A signalling to DVL3.
Revet I; Huizenga G; Koster J; Volckmann R; van Sluis P; Versteeg R; Geerts D
Cancer Lett; 2010 Mar; 289(2):195-207. PubMed ID: 19815336
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of WIF-1 and Wnt5a in patients with colorectal carcinoma: clinical significance.
Abdelmaksoud-Dammak R; Miladi-Abdennadher I; Saadallah-Kallel A; Khabir A; Sellami-Boudawara T; Frikha M; Daoud J; Mokdad-Gargouri R
Tumour Biol; 2014 Aug; 35(8):7975-82. PubMed ID: 24833087
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profile of quiescent and activated rat hepatic stellate cells implicates Wnt signaling pathway in activation.
Jiang F; Parsons CJ; Stefanovic B
J Hepatol; 2006 Sep; 45(3):401-9. PubMed ID: 16780995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]